A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma
Clinical trial NCT03800706 · UNKNOWN
Trial details
- NCT number
- NCT03800706
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2021-06-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.